ÂÜÀòÂÒÂ×

Mark Bonyhadi, Ph.D., currently serves on the Scientific Advisory Board at cTRL Therapeutics and as an Independent Board Member at Integra Therapeutics and TC BioPharm, alongside running Bonyhadi LLC Consulting since May 2018. With prior experience as the Vice President of Research and Head of Research at Juno Therapeutics from 2013 to 2018, Mark also held leadership roles at Life Technologies, focusing on clinical business development and cell therapy. Mark’s educational background includes a Ph.D. in Immunology from the University of California, Berkeley, and a Bachelor of Arts in Biology from Reed College.